189 related articles for article (PubMed ID: 31159611)
1. Improving fibrinolysis in venous thromboembolism: impact of fibrin structure.
Undas A; Natorska J
Expert Rev Hematol; 2019 Aug; 12(8):597-607. PubMed ID: 31159611
[No Abstract] [Full Text] [Related]
2. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
Zabczyk M; Plens K; Wojtowicz W; Undas A
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
[TBL] [Abstract][Full Text] [Related]
3. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
Piróg M; Piwowarczyk S; Undas A
Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
[TBL] [Abstract][Full Text] [Related]
4. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.
Undas A; Zawilska K; Ciesla-Dul M; Lehmann-Kopydłowska A; Skubiszak A; Ciepłuch K; Tracz W
Blood; 2009 Nov; 114(19):4272-8. PubMed ID: 19690336
[TBL] [Abstract][Full Text] [Related]
5. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis in Venous Thromboembolism.
Undas A
Semin Thromb Hemost; 2021 Jul; 47(5):480-489. PubMed ID: 33878786
[TBL] [Abstract][Full Text] [Related]
7. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
Wójcik M; Zaręba L; Undas A
Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
Ząbczyk M; Natorska J; Undas A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562624
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
10. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
11. Novel antithrombotic strategies for treatment of venous thromboembolism.
Weitz JI; Chan NC
Blood; 2020 Jan; 135(5):351-359. PubMed ID: 31917385
[TBL] [Abstract][Full Text] [Related]
12. Role of selectins and fibrinolysis in VTE.
Wakefield TW; Myers DD; Henke PK
Thromb Res; 2009; 123 Suppl 4():S35-40. PubMed ID: 19303502
[TBL] [Abstract][Full Text] [Related]
13. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
[TBL] [Abstract][Full Text] [Related]
14. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
[TBL] [Abstract][Full Text] [Related]
15. Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke.
Wyseure T; Rubio M; Denorme F; Martinez de Lizarrondo S; Peeters M; Gils A; De Meyer SF; Vivien D; Declerck PJ
Blood; 2015 Feb; 125(8):1325-32. PubMed ID: 25540192
[TBL] [Abstract][Full Text] [Related]
16. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
[TBL] [Abstract][Full Text] [Related]
17. Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation.
Siudut J; Natorska J; Zabczyk M; Zajac D; Seweryn K; Rąpała-Kozik M; Undas A
Thromb Res; 2018 Mar; 163():12-18. PubMed ID: 29324332
[TBL] [Abstract][Full Text] [Related]
18. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.
Voukalis C; Lip GY; Shantsila E
Expert Opin Pharmacother; 2016 Oct; 17(15):2033-47. PubMed ID: 27667112
[TBL] [Abstract][Full Text] [Related]
20. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]